FDA — authorised 17 June 2009
- Application: NDA022165
- Marketing authorisation holder: ASSERTIO SPECLTY
- Local brand name: CAMBIA
- Indication: FOR SOLUTION — ORAL
- Status: approved
🇺🇸 Diclofenac Potassium for Oral Solution in United States
FDA authorised Diclofenac Potassium for Oral Solution on 17 June 2009
Marketing authorisation
Frequently asked questions
Is Diclofenac Potassium for Oral Solution approved in United States?
Yes. FDA authorised it on 17 June 2009.
Who is the marketing authorisation holder for Diclofenac Potassium for Oral Solution in United States?
ASSERTIO SPECLTY holds the US marketing authorisation.